Browse All

Current Filters

CLEAR FILTER x

TITLE

Cannabis Use Disorder in Multiple Sclerosis: Characterization of a National Sample of Patients Seeking Treatment

Long-term Efficacy of the Sphingosine 1-Phosphate Receptor Modulator Ozanimod by Age Category in Patients with Relapsing Multiple Sclerosis: Final Results from Two Phase 3 Trials and an Open-label Extension Trial

Author:Steinman, Lawrence   Selmaj, Krzysztof   Comi, Giancarlo   Bar-Or, Amit   Arnold, Douglas   Hartung, Hans-Peter   Montalban, Xavier   Havrdova, Eva   Sheffield, James   Cheng, Chun-Yen   Reardon, Jennifer   Riolo, Jon   Deboer, Erik   Kappos, Ludwig   Cohen, Jeffrey   Cree, Bruce   

Session Name:P2: Multiple Sclerosis: Clinical Practice and Decision Making 2  

Topic:Multiple Sclerosis  

Program Number:P2.007  

Author Institution:Department of Neurology and Neurological Sciences, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, California, Stanford, CA  Center for Neurology, Lódz, Poland, and Collegium Medicum, Department of Neurology, University of Warmia and Mazury, Olsztyn, Poland, Lodz, Poland  Vita-Salute San Raffaele University and Casa di Cura del Policlinico, Milan, Italy, Milan, Italy  Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Philadelphia, PA  NeuroRx Research and Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada, Montreal, QC, Canada  Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany  Brain and Mind Centre, University of Sydney, Australia  Department of Neurology, Medical University of Vienna, Austria  and Palacký University Olomouc, Olomouc, Czech Republic, Dusseldorf, Germany  Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain  Department of Neurology and Center for Clinical Neuroscience, First Medical Faculty, Charles University, Prague, Czech Republic, Prague, Czech Republic  Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ  Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland  Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH  Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, San Francisco, CA  

Therapeutic Decision-making from the Perspective of Patients with Relapsing-remitting Multiple Sclerosis

Author:Sabin Munoz, Julia   Salas Alonso, Elisa   Martín-Martínez, Jesús   Candeliere-Merlicco, Antonio   Barrero, Francisco   Alonso Torres, Ana   Sánchez-Menoyo, José Luis   Borrega Canelo, Laura   Rodríguez-Rodríguez, María   Gómez-Gutiérrez, Montserrat   Eichau Madueno, Sara   Hernández-Pérez, Miguel Ángel   Calles, Carmen   Fernández-Díaz, Eva   Carmona, Olga   Orvíz, Aida   López-Real, Ana   López-Muñoz, Pablo   Mendoza, Amelia   Aguera Morales, Eduardo   Maurino, Jorge   

Session Name:P2: Multiple Sclerosis: Clinical Practice and Decision Making 2  

Topic:Multiple Sclerosis  

Program Number:P2.008  

Author Institution:Hospital Universitario Puerta de Hierro, Majadahonda, Spain  Roche Farma, Madrid, Spain  Hospital Universitario Miguel Servet, Zaragoza, Spain  Hospital Rafael Méndez, Lorca, Spain  Hospital Clínico Universitario San Cecilio, Granada, Spain  Hospital Regional Universitario de Málaga, Málaga, Spain  Hospital de Galdakao-Usansolo, Galdakao, Spain  HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN, ALCORCON, Spain  Hospital Universitario Lucus Augusti, Lugo, Spain  Hospital San Pedro de Alcántara, Cáceres, Spain  Hospital Universitario Virgen Macarena, Sevilla, Spain  Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain  Hospital Universitario Son Espases, Palma De Mallorca, Spain  Hospital Universitario de Albacete, Albacete, Spain  Fundació Salut Empordà, Figueres, Spain  Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain  Complejo Hospitalario Universitario A Coruña, A Coruña, Spain  Hospital Arnau de Vilanova, Llíria, Spain  Complejo Asistencial de Segovia, Segovia, Spain  Hospital Universitario Reina Sofía, Cordoba, Spain  

Drug Eruption After Subcutaneous Ofatumumab Exposure in Two Patients with Relapsing Multiple Sclerosis